Costs could go up for API distributors in Europe

02/24/2013 | In-PharmaTechnologist.com

Firms that transport active pharmaceutical ingredients in European Union countries could face increased costs of doing business if draft guidelines issued earlier this month are adopted. The guidelines would require distributors to have quality management and risk identification procedures, appoint key personnel at distributions points, be registered under the Falsified Medicines directive and ensure warehouses are capable of protecting shipments, among other provisions.

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC